Actionable news
0
All posts from Actionable news
Actionable news in MRK: MERCK & CO. Inc,

Merck's marketing application for Cladribine tablets accepted for review in Europe

The European Medicines Agency (EMA) accepts for review Merck's (NYSE:MRK) Marketing Authorization Application (MAA) seeking approval of Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS).

Head of Global R&D for...


More